Potent fibrinolysis inhibitor discovered by shape and electrostatic complementarity to the drug tranexamic acid.
Jonas Boström, J Andrew Grant, Ola Fjellström, Anders Thelin, David Gustafsson
文献索引:J. Med. Chem. 56(8) , 3273-80, (2013)
全文:HTML全文
摘要
Protein-protein interfaces provide an important class of drug targets currently receiving increased attention. The typical design strategy to inhibit protein-protein interactions usually involves large molecules such as peptides and macrocycles. One exception is tranexamic acid (TXA), which, as a lysine mimetic, inhibits binding of plasminogen to fibrin. However, the daily dose of TXA is high due to its modest potency and pharmacokinetic properties. In this study, we report a computational approach, where the focus was on finding electrostatic potential similarities to TXA. Coupling this computational technique with a high-quality low-throughput screen identified 5-(4-piperidyl)-3-isoxazolol (4-PIOL) as a potent plasminogen binding inhibitor with the potential for the treatment of various bleeding disorders. Remarkably, 4-PIOL was found to be more than four times as potent as the drug TXA.
相关化合物
相关文献:
2015-01-01
[PLoS ONE 10 , e0128720, (2015)]
2015-11-01
[ChemMedChem 10 , 1846-62, (2015)]
2014-06-01
[Acta Pharmacol. Sin. 35(6) , 846-52, (2014)]
2015-08-01
[J. Comp. Neurol. 523 , 1701-16, (2015)]
2016-01-01
[Immunobiology 221 , 94-102, (2015)]